What is 10x Genomics, Inc.'s operating cash flow?

10x Genomics, Inc. (TXG) reported operating cash flow of $26.12M in Q1 2026.

How has 10x Genomics, Inc.'s operating cash flow changed year-over-year?

10x Genomics, Inc.'s operating cash flow decreased by 24.0% year-over-year, from $34.35M to $26.12M.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

10x Genomics, Inc. TXG Operating Cash Flow

Operating Cash Flow at other companies

TEC

Bio-TechneTECH

$86.66M+111%

BrukerBRKR

$71.2M+9.5%

IlluminaILMN

$289M+20.4%

Twist Bioscience CorporationTWST

-$17.56M-35.2%

RevvityRVTY

$115.23M-10.1%

Bio-Rad LaboratoriesBIO

$108.1M-16.8%

Other financials

Income statement

See full

Revenue$150.8M-2.6%

Gross profit$106.2M+0.7%

Operating income-$17.0M+56.7%

Net income-$13.5M+60.8%

EPS (diluted)-$0.10+64.3%

Balance sheet

See full

Cash & equivalents$490.3M+30.0%

Total debt$81.4M+1.6%

Total equity$814.3M+15.2%

Total assets$1.0B+12.4%

Cash flow

See full

CapEx$1.6M-15.6%

Free cash flow$24.5M-24.4%

Valuation

See full

Market cap$4.41B+154%

Enterprise value$4B+199%

P/S6.9×+4.1×

Profitability

See full

Gross margin69.6%+1.2pp

Operating margin-6.1%-2.7pp

Net margin-3.5%-1.6pp

FCF margin19.1%—

Returns & leverage

See full

Return on equity-3%-1.4pp

Debt / equity0.1×0.0×

Current ratio5.9×+0.5×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is 10x Genomics, Inc.'s operating cash flow?: 10x Genomics, Inc. (TXG) reported operating cash flow of $26.12M in Q1 2026.
How has 10x Genomics, Inc.'s operating cash flow changed year-over-year?: 10x Genomics, Inc.'s operating cash flow decreased by 24.0% year-over-year, from $34.35M to $26.12M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.